Results 71 to 80 of about 631 (138)

Calpain signaling: from biology to therapeutic opportunities in neurodegenerative disorders. [PDF]

Front Vet Sci, 2023
Metwally E, Al-Abbadi HA, Hussain T, Murtaza G, Abdellatif AM, Ahmed MF.   +5 more
europepmc   +1 more source

Regional variation of thigh muscle fat infiltration in patients with neuromuscular diseases compared to healthy controls. [PDF]

Quant Imaging Med Surg, 2021
Greve T, Burian E, Zoffl A, Feuerriegel G, Schlaeger S, Dieckmeyer M, Sollmann N, Klupp E, Weidlich D, Inhuber S, Löffler M, Montagnese F, Deschauer M, Schoser B, Bublitz S, Zimmer C, Karampinos DC, Kirschke JS, Baum T.   +18 more
europepmc   +1 more source

CAPN3: A muscle‑specific calpain with an important role in the pathogenesis of diseases (Review). [PDF]

Int J Mol Med, 2021
Chen L, Tang F, Gao H, Zhang X, Li X, Xiao D.   +5 more
europepmc   +1 more source

Variants of CAPN3 cause limb-girdle muscular dystrophy type 2A in two Chinese families. [PDF]

Exp Ther Med, 2021
Zheng J, Xu X, Zhang X, Wang X, Shu J, Cai C.   +5 more
europepmc   +1 more source

Calpainopathy Can Manifest Itself in Not Only Skeletal Muscle but Also the Brain and Myocardium. [PDF]

Intern Med
Finsterer J.
europepmc   +1 more source

Key biomarkers and latent pathways of dysferlinopathy: Bioinformatics analysis and in vivo validation. [PDF]

Front Neurol, 2022
Xie Y, Li YH, Chen K, Zhu CY, Bai JY, Xiao F, Tan S, Zeng L.   +7 more
europepmc   +1 more source

A review of recent studies on CRISPR/Cas9-mediated genome editing in a variety of muscle-related genetic disorders. [PDF]

J Transl Med
Lyu G, Li P, Lang W.
europepmc   +1 more source

Serum metabolomic signatures of patients with rare neurogenetic diseases: an insight into potential biomarkers and treatment targets. [PDF]

Front Mol Neurosci
Wijekoon N, Gonawala L, Ratnayake P, Sirisena D, Gunasekara H, Dissanayake A, Amaratunga D, Steinbusch HWM, Hathout Y, Hoffman EP, Dalal A, Mohan C, de Silva KRD.   +12 more
europepmc   +1 more source

Alternations of NF-κB Signaling by Natural Compounds in Muscle-Derived Cancers. [PDF]

Int J Mol Sci, 2023
Radzka J, Łapińska Z, Szwedowicz U, Gajewska-Naryniecka A, Gizak A, Kulbacka J.   +5 more
europepmc   +1 more source

Progress on cell therapy for skeletal muscle disorders. [PDF]

Adv Drug Deliv Rev
Azzag K, Perlingeiro RCR.
europepmc   +1 more source